Deploys private capital into growth-stage technology and healthcare companies, combining active board work with financial and operational playbooks to drive scale and exit readiness. Adam Amante brings experience across venture and corporate development roles, leading deal execution, diligence and post-investment value creation for minority and control investments. Market relevance centers on revenue-driven growth strategies, partnerships that accelerate distribution, and pragmatic governance improvements to improve liquidity timelines.
Deploys private capital into growth-stage technology and healthcare companies, combining active board work with financial and operational playbooks to drive scale and exit readiness. Adam Amante brings experience across venture and corporate development roles, leading deal execution, diligence and post-investment value creation for minority and control investments. Market relevance centers on revenue-driven growth strategies, partnerships that accelerate distribution, and pragmatic governance improvements to improve liquidity timelines.
Focuses on growth-stage technology and healthcare investments, combining minority and control stakes with active board involvement and hands-on operational playbooks to accelerate scale and exit readiness. Underwrites opportunities through revenue and unit-economics-driven diligence, prioritizing capital efficiency, commercial partnerships that expand distribution, and governance fixes that shorten liquidity timelines. Deploys milestone-based capital, targets three- to seven-year horizons, and leans on repeatable go-to-market and partnership plays to de-risk execution.
Focuses on growth-stage technology and healthcare investments, combining minority and control stakes with active board involvement and hands-on operational playbooks to accelerate scale and exit readiness. Underwrites opportunities through revenue and unit-economics-driven diligence, prioritizing capital efficiency, commercial partnerships that expand distribution, and governance fixes that shorten liquidity timelines. Deploys milestone-based capital, targets three- to seven-year horizons, and leans on repeatable go-to-market and partnership plays to de-risk execution.
| Trades 340 | Longs Won 201/340 59% | Profit Factor 9.4 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $259,433.9 |
| Average Win $103,499.91 | Best Trade (Aug 17) $3.76M | Sharpe Ratio -9.7 |
| Average Loss -$15,920.65 | Worst Trade (Aug 02) -$316,863.73 | Z-Score 2.04 (95.86%) |
| Commissions $0 | Avg. Trade Length 10m 4w 1d | Expectancy $54,677.97 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 6,667 | 6,000 | 5,333 | 4,667 | 4,000 | 3,333 | 2,667 | 2,000 | 1,333 | 667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 16,827 | $4.18M | $5.2M | - | $1.02M | 24.38% | -7.354% |
AEP American Electric Power Company, Inc. | 5,628 | $572,030 | $719,539.8 | - | $147,509.8 | 25.79% | +0.055% |
AMLP Alerian MLP ETF | 18,606 | $979,403 | $1.03M | - | $49,880.92 | 5.09% | +0.894% |
AMZN Amazon.com Inc | 5,147 | $1.13M | $1.4M | - | $268,088.68 | 23.73% | +15.321% |
APH Amphenol Corporation | 25,880 | $472,691.46 | $1.04M | - | $567,037.54 | 119.96% | +0.551% |
APO Apollo Global Management, Inc. | 2,018 | $321,892.19 | $253,440.62 | - | -$68,451.57 | -21.27% | +4.441% |
AVEM Avantis Emerging Markets Equity ETF | 8,963 | $608,279.66 | $802,278.13 | - | $193,998.47 | 31.89% | +0.101% |
AVGO Broadcom Inc. | 3,606 | $857,323.42 | $1.4M | - | $546,420.26 | 63.74% | +0.371% |
BHP BHP Group Ltd. | 3,161 | $229,927 | $267,072.89 | - | $37,145.89 | 16.16% | -1.641% |
COST Costco Wholesale Corporation | 1,028 | $959,495.52 | $978,542.93 | - | $19,047.41 | 1.99% | -0.239% |
CRWD CrowdStrike Holdings, Inc. | 5,116 | $605,953.02 | $976,439.76 | - | $370,486.74 | 61.14% | +3.045% |
CVX Chevron Corporation | 1,065 | $220,458 | $209,623.95 | - | -$10,834.05 | -4.91% | +2.35% |
EME EMCOR Group, Inc. | 461 | $340,364 | $367,615.23 | - | $27,251.23 | 8.01% | -0.616% |
ESGV Vanguard ESG U.S. Stock ETF | 9,614 | $1.04M | $1.27M | - | $233,423.74 | 22.54% | +0.679% |
ESML iShares ESG Aware MSCI USA Small-Cap ETF | 4,259 | $200,253 | $228,793.48 | - | $28,540.48 | 14.25% | -0.167% |
FEZ SPDR Euro Stoxx 50 ETF | 9,524 | $601,628.34 | $664,489.48 | - | $62,861.14 | 10.45% | +0.1% |
FIX Comfort Systems USA, Inc. | 1,216 | $515,499.78 | $2.1M | - | $1.59M | 308.01% | +1.876% |
FTEC Fidelity MSCI Information Technology Index ETF | 1,320 | $244,175.76 | $356,532.01 | - | $112,356.25 | 46.01% | -0.354% |
GLAD Gladstone Capital Corporation | 14,116 | $398,210.11 | $263,545.72 | - | -$134,664.39 | -33.82% | -1.007% |
GLD SPDR Gold Shares | 3,099 | $773,329.87 | $1.15M | - | $378,072.62 | 48.89% | -1.49% |